Pharmaceutical Additive Manufacturing With Unified Multi-Nozzle Flow Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing 3D printing technologies face challenges in achieving high throughput, precision, and consistency when manufacturing pharmaceutical dosage units like tablets and caplets, particularly due to the high viscosity of printing materials and the inability to coordinate multiple nozzles effectively, leading to inconsistent output and high operational costs.

Innovation Solution

A system with a material supply module, flow distribution module, and multiple nozzles controlled by controllers to dispense precise flows, along with closed-loop control systems to manage temperature, pressure, and nozzle openings, ensuring consistent production of pharmaceutical dosage units.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If multiple printing devices are used to increase throughput, then productivity is improved, but manufacturing precision and consistency deteriorate due to hardware and software configuration inconsistencies

Engineering Contradiction:
ImprovethroughputVSAvoidconsistency
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent merges multiple printing devices into a single integrated system with unified hardware and software configuration. Multiple nozzles are coordinated through a centralized controller that ensures consistent operation across all printing heads, eliminating the inconsistency problems that arise from coordinating separate devices.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The system segments the printing function into multiple nozzles that operate in parallel under unified control. Each nozzle can be independently controlled for precise material dispensing while maintaining overall system consistency through centralized coordination, allowing high throughput without sacrificing precision.

Inventive Principle:
Principle #1Segmentation

2Ease of manufacture

If traditional 3D printing systems are used with high viscosity materials, then ease of manufacture is maintained, but manufacturing precision deteriorates due to inability to coordinate multiple nozzles and control material release

Engineering Contradiction:
Improveprocess simplicityVSAvoidconsistency
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The system implements closed-loop control with feedback mechanisms that monitor and adjust material dispensing from multiple nozzles in real-time. This ensures precise coordination of high viscosity materials across all nozzles, maintaining consistency in pharmaceutical dosage unit production while keeping the process manageable through automated control.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

A centralized control system acts as an intermediary between the material supply and multiple nozzles. This mediator coordinates the operation of all nozzles, controlling the release of high viscosity materials in a precise and consistent manner, thereby achieving uniformity in the printed pharmaceutical units.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If multiple nozzles are used to increase throughput, then productivity is improved, but device complexity increases due to coordination requirements

Engineering Contradiction:
ImprovethroughputVSAvoidsystem complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The system uses a universal centralized controller that manages multiple nozzles through a single interface and control architecture. This multi-functional controller handles material flow regulation, nozzle coordination, and printing parameters for all nozzles, reducing operational complexity despite the increased number of printing elements.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system achieves high-throughput, precise, and cost-efficient manufacturing of pharmaceutical dosage units with consistency within and across batches, minimizing inconsistencies to less than 10% in weight and volume, and supports parallel printing across multiple stations.

Implementation Method 1

material in the form of a filament is fed through a heated nozzle, which melts the material onto a surface

Methodology Applied
Scientific EffectHeating: Heating

Implementation Method 2

Other additive manufacturing methods utilize non-filamentous materials that are molten and pressurized before being dispensed through a printing nozzle

Methodology Applied
Scientific EffectPressurization: Pressurisation

Data Source

PatentUS12384112B2High-throughput and high-precision pharmaceutical additive manufacturing system
Publication Date: 2025.08.12 TRIASTEK INC
  • US12384112B2 patent drawing
  • US12384112B2 patent drawing
  • US12384112B2 patent drawing

AI summary

The present disclosure relates generally to manufacturing pharmaceutical products using additive manufacturing technology. An exemplary printing system comprises: a material supply module for receiving a set of printing materials; a flow distribution module comprising a flow distribution plate, wherein the material supply module is configured to transport a single flow corresponding to the set of printing materials to the flow distribution plate; wherein the flow distribution plate comprises a plurality of channels for dividing the single flow into a plurality of flows; a plurality of nozzles, wherein the plurality of nozzles comprises a plurality of needle-valve mechanisms; one or more controllers for controlling the plurality of needle-valve mechanisms to dispense the plurality of flows based on a plurality of nozzle-specific parameters; and a printing platform configured to receive the dispensed plurality of flows, wherein the printing platform is configured to move to form a batch of the pharmaceutical product.